CN109251163B - Resolution method of indoline-2-formic acid compound and intermediate thereof - Google Patents

Resolution method of indoline-2-formic acid compound and intermediate thereof Download PDF

Info

Publication number
CN109251163B
CN109251163B CN201710576038.7A CN201710576038A CN109251163B CN 109251163 B CN109251163 B CN 109251163B CN 201710576038 A CN201710576038 A CN 201710576038A CN 109251163 B CN109251163 B CN 109251163B
Authority
CN
China
Prior art keywords
compound
acid
indoline
iii
resolving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201710576038.7A
Other languages
Chinese (zh)
Other versions
CN109251163A (en
Inventor
李旺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian Yongda Suli Pharmaceutical Co ltd
Original Assignee
Jiangsu Yongda Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Yongda Pharmaceutical Co ltd filed Critical Jiangsu Yongda Pharmaceutical Co ltd
Priority to CN201710576038.7A priority Critical patent/CN109251163B/en
Publication of CN109251163A publication Critical patent/CN109251163A/en
Application granted granted Critical
Publication of CN109251163B publication Critical patent/CN109251163B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)

Abstract

The invention discloses a resolution method of indoline-2-formic acid compounds and intermediates thereof. The resolution method of the indoline-2-formic acid compound comprises the following steps: in a solvent, carrying out a salt forming reaction on the compound V and a resolving agent compound II to obtain compounds III and III'; the compound V is a mixture of a compound shown in a formula I and a compound shown in a formula I'. The resolution method has the advantages of high yield, high resolution purity, stable compound in the resolution process, high subsequent racemization yield, repeated resolution and optimized material utilization, and the compound can be recycled for multiple times.

Description

Resolution method of indoline-2-formic acid compound and intermediate thereof
Technical Field
The invention relates to a resolution method of indoline-2-formic acid compounds and intermediates thereof.
Background
Perindopril (Perindopril), which was marketed in france in 1989 as a mercapto-free ACE inhibitor, was mainly used for the treatment of essential hypertension and heart failure. The preparation has the advantages of other ACE inhibitors, longer action time, smaller side effect, better tolerance and good market prospect.
Figure BDA0001350980440000011
S-indoline-2-carboxylic acid (I) is an important intermediate for synthesizing perindopril, and the conventional synthesis process is as follows:
Figure BDA0001350980440000012
the resolving agent for resolving in the two routes is chiral organic alkali, commonly used is R-alpha-methyl phenethylamine, and the structural formula is as follows:
Figure BDA0001350980440000021
the R-alpha-methyl phenethylamine has poor resolution effect, the resolution salt obtained by one-time resolution cannot achieve better separation effect, and the resolution effect can be achieved only by recrystallizing the resolution salt for many times. Therefore, the method has poor resolution effect, low yield and higher production cost.
The chemical resolution of S (-) -indoline-2-formic acid, and the resolution of R, S-indoline-2-formic acid and R (+) -alpha-phenylethylamine to obtain S (-) -indoline-2-formic acid. Due to unstable chemical property of indoline-2-formic acid, the method has low resolution yield. The racemization of the recovered R (+) -indoline-2-formic acid generates a large amount of tar and has low yield.
Disclosure of Invention
The invention aims to overcome the defects of low yield of a resolution method of an indoline-2-formic acid compound and unstable compound in the resolution process in the prior art, and provides the resolution method of the indoline-2-formic acid compound and an intermediate thereof. The resolution method has the advantages of high yield, high resolution purity, stable compound in the resolution process, high subsequent racemization yield, repeated resolution and optimized material utilization, and the compound can be recycled for multiple times.
The invention provides a resolution method of indoline-2-formic acid compounds, which comprises the following steps: in a solvent, carrying out a salt forming reaction on the compound V and a resolving agent compound II to obtain compounds III and III';
Figure BDA0001350980440000031
the compound V is a mixture of a compound shown in a formula I and a compound shown in a formula I';
Figure BDA0001350980440000032
the compound II is a compound shown as a formula II-1 or a compound shown as a formula II-2;
Figure BDA0001350980440000033
wherein R is 1 is-H, -OH, -NO 2 Or C 1 ~C 3 Alkyl of (2)An oxy group;
R 2 is absent or C 1 ~C 3 Alkyl groups of (a);
R 3 is C 1 ~C 4 Alkyl groups of (a);
R 4 is C 1 ~C 3 Alkyl, phenyl or tert-butoxy of (a);
when the compound II is a compound II-1, the compounds III and III 'are respectively a compound III-1 and a compound III' -1 shown as follows:
Figure BDA0001350980440000034
when the compound II is a compound II-2, the compounds III and III 'are respectively a compound III-2 and a compound III' -2 shown as follows:
Figure BDA0001350980440000041
through the resolution method, the indoline-2-formic acid compound can be resolved to obtain the indoline-2-formic acid compound with a single configuration, wherein the indoline-2-formic acid compound with the single configuration refers to the indoline-2-formic acid compound which is completely in the single configuration or exists in the configuration with a certain configuration as a main advantage configuration.
In the invention, R is 1 preferably-H, -NO 2 Or a methoxy group.
R is as described 2 Preferably absent or C 1 ~C 2 Alkyl group of (1).
Said C 1 ~C 4 The alkyl group of (a) is preferably a methyl group, an ethyl group, an isopropyl group or a butyl group.
In the present invention, the compound V is preferably a compound I and a compound I' at a molar ratio of (2:3) to (3:2), and more preferably at a molar ratio of 1:1.
The compound II is preferably selected from one of phenyl glycine methyl ester, phenyl glycine ethyl ester, 4-nitrophenyl glycine butyl ester, phenylalanine methyl ester, phenylalanine ethyl ester, phenyl butyric acid isopropyl ester or enantiomer of 4-methoxy phenylalanine methyl ester.
In the invention, the solvent can be a conventional solvent for resolving the compounds in the field, for example, the solubility difference of the salified chiral compounds is large, which is beneficial to separation; in the present invention, water and/or alcohol solvents are preferable; the alcohol solvent is preferably one or more of methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol and benzyl alcohol.
In the present invention, the molar ratio of the compound V to the compound II can be determined by referring to the conventional amounts in chiral resolution in the art, such as (10; more preferably (1:1) to (1.05).
The temperature of the reaction may be a temperature conventional in the art for such salt-forming reactions, for example, heating to reflux the solvent, preferably 50 ℃ to 100 ℃ in the present invention; also, the temperature should not exceed the reflux temperature, as is common knowledge in the art.
In the present invention, the mass ratio of the indoline-2-carboxylic acid compound to the solvent is preferably (1:3) to (1.
After the salt-forming reaction is finished, the method can further comprise the following post-treatment operations: cooling and filtering; both the cooling and the filtration can be performed according to methods conventional in the art.
The resolution method of the indoline-2-formic acid compound can also comprise the following steps: the compound III or III 'and acid are subjected to free reaction to obtain a compound I or I',
Figure BDA0001350980440000051
wherein, the substituent R 1 、R 2 、R 3 And R 4 The definitions of (A) and (B) are as described above.
Said R 1 preferably-H, -NO 2 Or a methoxy group.
Said R 2 Preferably absent or C 1 ~C 2 The alkyl group of (1).
Said C 1 ~C 4 The alkyl group of (a) is preferably a methyl group, an ethyl group, an isopropyl group or a butyl group.
The acid is conventional in the art for such free reaction, such as one or more of sulfuric acid, nitric acid, phosphoric acid and hydrochloric acid, preferably hydrochloric acid in the present invention.
The molar ratio of said compound III or III' to said hydride ion in the acid may be a molar ratio customary in the art for such free reactions, and in the present invention is preferably (1:1) - (1.2; more preferably (1.
The reaction temperature may be a temperature conventional in the art for such dissociation reactions, and in the present invention, is preferably 10 to 30 ℃.
The resolution method of the indoline-2-formic acid compound can also comprise the following steps: hydrolyzing the compound I or I 'with acid to obtain a compound IV or IV',
Figure BDA0001350980440000061
wherein, the substituent R 4 The definition of (A) is as described above.
The acid is an acid conventional in the art for such hydrolysis reactions, such as one or more of sulfuric acid, phosphoric acid and hydrochloric acid, with hydrochloric acid being particularly preferred in the present invention.
The amount of said acid may be that conventionally used in the art for such hydrolysis reactions, and the molar ratio of the hydrogen radical ion in said acid to said compound I or I' in the present invention is preferably (2.5; more preferably 3:1.
The acid concentration can be the concentration conventional in the hydrolysis reaction of the type in the field, and is preferably 10-15 percent in the invention; more preferably 10%.
The reaction temperature can be the temperature conventional in the hydrolysis reaction, and is preferably 100-110 ℃ in the invention; more preferably from 100 to 105 ℃.
The progress of the hydrolysis reaction can be monitored by methods of testing conventional in the art (e.g., TLC, HPLC or NMR), typically by the end point of the reaction being the disappearance or no longer being reacted with the starting material. In the present invention, the reaction is preferably carried out for 3 to 5 hours.
After the hydrolysis reaction is finished, the method also comprises the following post-treatment steps: after the reaction is finished, cooling and adjusting the pH value to 4.0; preferably cooling to 35 deg.C, adjusting pH to 4.0 with liquid alkali or ammonia water, and filtering.
The resolution method of the indoline-2-formic acid compound can also comprise the following steps: and carrying out racemization reaction on the compound IV or IV 'and acid anhydride to obtain a mixture of the compound IV and the compound IV'.
The mixture of said compound IV and said compound IV' can be further subjected to said resolution by further subjecting said compound V to an acylation reaction as is conventional in the art.
The acid anhydride may be an acid anhydride conventional in the art for such racemization reaction, and in the present invention, one or more of acetic anhydride, propionic anhydride, butyric anhydride and phthalic anhydride are preferable.
The racemization reaction can be added with an organic solvent which is conventional in the racemization reaction in the field, and in the invention, one or more of acetic acid, propionic acid, butyric acid and toluene are preferred.
The temperature of the reaction may be a temperature conventional in the art for such racemization, for example, 100 to 180 ℃ and, in the present invention, preferably 100 to 120 ℃.
The invention also provides any one of the following compounds:
Figure BDA0001350980440000071
wherein, the substituent R 1 、R 2 、R 3 And R 4 The definitions of (A) and (B) are as described above.
On the basis of the common knowledge in the field, the above preferred conditions can be combined randomly to obtain the preferred embodiments of the invention.
The reagents and starting materials used in the present invention are commercially available.
The positive progress effects of the invention are as follows: the invention provides a resolution method of the indoline-2-formic acid compound and an intermediate thereof. The resolution method has the advantages of high yield, high resolution purity, stable compound in the resolution process, high subsequent racemization yield, repeated resolution and optimized material utilization, and the compound can be recycled for multiple times.
Detailed Description
The invention is further illustrated by the following examples, which are not intended to limit the scope of the invention. The experimental methods without specifying specific conditions in the following examples were selected according to the conventional methods and conditions, or according to the commercial instructions.
Example 1
1) 100g of N-acetylindoline-2-carboxylic acid and 500g of water are put into a 1000ml three-necked bottle, and 92g of L-phenylglycine ethyl ester is added under stirring. After the addition, the temperature is raised to reflux, and the temperature is kept for 1 hour. Stirring and cooling to 10 deg.C, suction-filtering to obtain white solid A1:65g (yield 69.4% based on L-compound, purity 84% ee), optically rotating [ alpha ]] 25 D And = 90. The mother liquor was adjusted to pH =1 with 30% hydrochloric acid and filtered to give white dextrorotatory B1:67g.
2) And preparation of S-N-acetyl indoline-2-formic acid: 100g of A1 resolving salt and 400g of water are put into a 1000ml three-necked bottle, and 35g of 30% concentrated hydrochloric acid is dropwise added into the bottle while stirring at 10-30 ℃. After the dropping, 51g of white powder was obtained by suction filtration. (yield 95.8%)
3) 150g of concentrated hydrochloric acid and 250g of water were put into a 1000ml three-necked flask, and 100g of white powder was added thereto with stirring. After the addition, the temperature is slowly raised, the mixture is refluxed at 105 ℃ for 5 hours, and then is cooled to 35 ℃ after the reflux. Liquid caustic soda was added dropwise to adjust pH =4.0, and the mixture was washed with suction filtration and water to obtain 65g of a white solid (yield 82.3%, isomer <0.5%, optical rotation-115 ℃).
4) 100g of the B1 dextrorotatory substance, 700g of glacial acetic acid and 100g of acetic anhydride are put into a 1000ml three-neck bottle. Stirring and heating to 120 ℃, refluxing and preserving heat for 5 hours. Finish the heat preservationAnd concentrating under reduced pressure to dryness. Adding 800g water, dispersing at 80 deg.C, stirring, cooling to 10 deg.C, vacuum filtering to obtain 95g racemic mixture, optically rotating [ alpha ]] 25 D =0-0.5°。
Example 2
1) 100g of N-propionyl indoline-2-carboxylic acid and 500g of methanol were put into a 1000ml three-necked flask, and 82g of L-phenylalanine methyl ester was added thereto with stirring. After the addition, the temperature is raised to 50 to 60 ℃ and the temperature is kept for 1 hour. Stirring and cooling to 10 deg.C, suction-filtering to obtain white solid A2:63g (yield 69.4% based on L-compound, purity 99% ee) & alpha] 25 D = 88 °. The mother liquor was concentrated in methanol under reduced pressure, 500g of water was added to the residue, and the mixture was adjusted to pH =1 with 30% hydrochloric acid and filtered to obtain white dextrorotatory substance B2:62g.
2) And preparation of S-N-propionyl indoline-2-formic acid: 100g of A2 resolving salt and 400g of water are put into a 1000ml three-necked bottle, and 35g of 30% concentrated hydrochloric acid is dropwise added into the bottle while stirring at 10-30 ℃. After the dropping, 52g of white powder was obtained by suction filtration. (yield 94.4%)
3) 150g of concentrated hydrochloric acid and 250g of water were put into a 1000ml three-necked flask, and 100g of white powder was added thereto with stirring. After the addition, the temperature is slowly raised, the mixture is refluxed at 105 ℃ for 3 hours, and then is cooled to 35 ℃ after the reflux. Adding liquid caustic soda dropwise to adjust pH =4.0, filtering and washing with water to obtain 62g of white solid (yield 83.8%, isomer)<0.5%, optically active [ alpha ]] 25 D =-115°)。
4) 100g of the B2D-isomer, 700g of propionic acid and 100g of propionic anhydride were put into a 1000ml three-necked flask. Stirring and heating to 120 ℃, and keeping the temperature for 5 hours. After the temperature preservation is finished, concentrating under reduced pressure to be dry. Adding 800g water, dispersing at 80 deg.C, stirring, cooling to 10 deg.C, vacuum filtering to obtain 95g racemic mixture, optically rotating [ alpha ]] 25 D =0-0.5°。
Example 3
1) 100g of N-butyrylindoline-2-carboxylic acid and 500g of isopropanol are put into a 1000ml three-necked flask, and 95g of isopropyl L-phenylbutyrate acetate is added under stirring. After the addition, the temperature is raised to reflux, and the temperature is kept for 1 hour. Stirring and cooling to 10 deg.C, suction-filtering to obtain white solid A3:68g (yield 69.8% based on L-compound, purity 99% ee) & alpha & lt] 25 D And = 90. The mother liquor was concentrated under reduced pressure to isopropanol and 400g of water were added to the residueThe mixture was adjusted to pH =1 with 30% hydrochloric acid and filtered to obtain 61g of white dextrorotatory substance B3.
2) And preparation of S-N-butyryl indoline-2-formic acid: 100g of A3 resolving salt and 400g of water are put into a 1000ml three-necked bottle, and 30g of 30 percent concentrated hydrochloric acid is dropwise added into the bottle while stirring at 10 to 30 ℃. After the dripping, 48g of white powder was obtained by suction filtration. (yield 93.6%)
3) 150g of concentrated hydrochloric acid and 250g of water were put into a 1000ml three-necked flask, and 100g of white powder was added thereto with stirring. After the addition, the temperature is slowly raised, the mixture is refluxed at 105 ℃ for 3 hours, and then is cooled to 35 ℃ after the reflux. Liquid caustic soda was added dropwise to adjust pH =4.0, and the mixture was washed with suction filtration and water to obtain 60g of a white solid (yield 86.3%, isomer <0.5%, optical rotation-115 ℃).
4) 100g of B3D-isomer, 700g of butyric acid and 100g of butyric anhydride were put into a 1000ml three-necked flask. Stirring and heating to 120 ℃, and keeping the temperature for 5 hours. After the temperature preservation is finished, concentrating under reduced pressure to be dry. Adding 800g water, dispersing at 80 deg.C, stirring, cooling to 10 deg.C, vacuum filtering to obtain 95g racemic mixture, optically rotating [ alpha ]] 25 D =0-0.5°。
Example 4
1) 100g of N-benzoylindoline-2-carboxylic acid and 500g of ethanol were put into a 1000ml three-necked flask, and 72g of L-phenylalanine ethyl ester was added thereto with stirring. After the addition, the temperature is raised to reflux, and the temperature is kept for 1 hour. Stirring and cooling to 10 deg.C, suction-filtering to obtain white solid A4:60g (yield 69.6% based on L-compound, purity 99% ee), optically rotating [ alpha ]] 25 D And = 90. The mother liquor was concentrated in ethanol under reduced pressure, 400g of water was added to the residue, the pH was adjusted with 30% hydrochloric acid =1, and filtration was carried out to obtain 60g of white dextrorotatory B4.
2) And preparation of S-N-benzoyl indoline-2-formic acid: 100g of A4 split salt and 400g of water are put into a 1000ml three-neck flask, and 28g of 30% concentrated hydrochloric acid is added dropwise with stirring at 10-30 ℃. After dropping, 55g of white powder was obtained by suction filtration. (yield 94.8%)
3) 150g of concentrated hydrochloric acid and 250g of water were put into a 1000ml three-necked flask, and 100g of white powder was added thereto with stirring. After the addition, the temperature is slowly raised, the mixture is refluxed at 105 ℃ for 5 hours, and then is cooled to 35 ℃ after the reflux. Dropwise adding concentrated ammonia water to adjust pH =4.0, filtering and washing to obtain 53g of white solid (yield is 87.4%, isomer)<0.5%, optically active [ alpha ]] 25 D =-115°)。
4) 100g of B4D-isomer, 700g of toluene and 100g of phthalic anhydride were put into a 1000ml three-necked flask. Stirring and heating to reflux, and keeping reflux for 5 hours. After the heat preservation is finished, concentrating under reduced pressure to be dry. Adding 800g water, dispersing at 80 deg.C, stirring, cooling to 10 deg.C, vacuum filtering to obtain 95g racemic mixture, optically rotating [ alpha ]] 25 D =0-0.5°。
Example 5
1) 100g of N-acetyl indoline-2-formic acid and 500g of ethanol are put into a 1000ml three-necked bottle, and 123g of L-4-nitrophenylglycine butyl ester is added under stirring. After the addition, the temperature is raised to reflux, and the temperature is kept for 1 hour. Stirring and cooling to 10 deg.C, suction-filtering to obtain white solid A5:78g (yield 70% based on L-compound, purity 98%] 25 D And = 90. The mother liquor was concentrated in ethanol under reduced pressure, 400g of water was added to the residue, the pH was adjusted with 30% hydrochloric acid =1, and filtration was carried out to obtain 60g of white dextrorotatory substance B5.
2) And preparation of S-N-acetyl indoline-2-formic acid: 100g of A5 resolving salt and 400g of water are put into a 1000ml three-necked bottle, and 118.6g of 10% dilute sulfuric acid is dropwise added into the bottle at 10-30 ℃ while stirring. After the dripping, 42g of white powder was obtained by suction filtration. (yield 93.6%)
3) 400g of 15% sulfuric acid was added to a 1000ml three-necked flask, and 100g of S-N-acetylindoline-2-carboxylic acid white powder was added thereto with stirring. After the addition, the temperature was slowly raised, the mixture was refluxed at 105 ℃ for 5 hours, and then cooled to 35 ℃ after the reflux. Adding liquid caustic soda dropwise to adjust the pH to be =4.0, and performing suction filtration and water washing to obtain 67g of white solid (the yield is 84.3 percent, and the isomer is obtained<0.5%, optically active [ alpha ]] 25 D =-115°)。
Example 6
1) 100g of N-butyrylindoline-2-carboxylic acid and 500g of methanol were put into a 1000ml three-necked flask, and 84g of L-phenylglycine methyl ester was added thereto with stirring. After the addition, the temperature is raised to reflux, and the temperature is kept for 1 hour. Stirring and cooling to 10 deg.C, suction-filtering to obtain white solid A6:64g (66% yield based on L-compound, 98% purity) optically active [ alpha ] alpha] 25 D And = 90. The mother liquor was concentrated in methanol under reduced pressure, 400g of water was added to the residue, and the mixture was adjusted to pH =1 with 30% hydrochloric acid and filtered to obtain 58g of white dextrorotatory substance B6.
2) And preparation of S-N-butyryl indoline-2-formic acid: 100g of A6 resolving salt and 400g of water are put into a 1000ml three-necked flask, and 174g of 10% nitric acid is dropwise added into the flask under stirring at 10-30 ℃. After the dripping, 53.5g of white powder was obtained by suction filtration. (yield 91.6%)
3) 400g of 15% nitric acid was added to a 1000ml three-necked flask, and 100g of white powder was added thereto with stirring. After the addition, the temperature was slowly raised, the mixture was refluxed at 105 ℃ for 3 hours, and then cooled to 35 ℃ after the reflux. Adding liquid caustic soda dropwise to adjust pH =4.0, filtering and washing with water to obtain 59.5g of white solid (yield 85.1%, isomer)<0.5%, optically active [ alpha ]] 25 D =-115°)。
Example 7
1) 100g of N-propionyl indoline-2-carboxylic acid and 500g of methanol were put into a 1000ml three-necked flask, and 96g of L-4-methoxyphenylalanine methyl ester was added thereto under stirring. After the addition, the temperature is raised to reflux, and the temperature is kept for 1 hour. Stirring and cooling to 10 deg.C, suction-filtering to obtain white solid A7:68g (yield 69.6% based on L-compound, purity 99% ee) (. Alpha.) with optical rotation] 25 D And = 90. The mother liquor was concentrated in methanol under reduced pressure, 400g of water was added to the residue, and the mixture was adjusted to pH =1 with 30% hydrochloric acid and filtered to obtain 62g of white dextrorotatory B7.
2) And preparation of S-N-propionyl indoline-2-formic acid: 100g of A7 resolving salt and 400g of water are put into a 1000ml three-necked flask, and 90g of 10% phosphoric acid is dropwise added into the flask under stirring at 10-30 ℃. After the dripping, 52.5g of white powder was obtained by suction filtration. (yield 95.4%)
3) 400g of 10% phosphoric acid was added to a 1000ml three-necked flask, and 100g of white powder was added thereto with stirring. After the addition, the temperature is slowly raised, the mixture is refluxed at 105 ℃ for 5 hours, and then is cooled to 35 ℃ after the reflux. Adding liquid caustic soda dropwise to adjust pH =4.0, filtering and washing with water to obtain 62g of white solid (yield 83.8%, isomer)<0.5%, optically active [ alpha ]] 25 D =-115°)。
Example 8
100g of N-propionyl indoline-2-carboxylic acid and 500g of methanol were put into a 1000ml three-necked flask, and 82g of D-phenylalanine methyl ester was added thereto with stirring. After the stirring is finished, the temperature is raised to 50-60 ℃, and the temperature is kept for 1 hour. Stirring, cooling to 10 deg.C, and vacuum filtering to obtain white solid A2:63g (yield 69.4% calculated by dextrorotatory compound, purity ee = 99%), optically active [ alpha ] ("alpha")] 25 D =88°。
Comparative example 1
1) 70g of racemic indoline-2-formic acid, 630g of acetone and 70g of water are put into a 1000ml three-necked bottle, and 57g R (+) -alpha-phenylethylamine 57g is added under stirring. Stirring, heating to 30 deg.C, incubating for 2 hours, cooling to 10 deg.C, and filtering to obtain white solid A8:35g (yield 57.4% based on L-compound, purity 76% ee), optically rotating [ alpha ] -alpha] 25 D And = 45. The mother liquor was concentrated in acetone solution under reduced pressure, and 300g of water and 30% hydrochloric acid were added to the residue to adjust PH =3.5. Filtration gave 40g of recovered D-isomer B8 as a gray color.
2) Preparation of S (-) -indoline-2-carboxylic acid: to a 1000ml three-necked flask was added the salified solid A8:100g of water 400g, 47g of 30% hydrochloric acid was added dropwise with stirring at 30 to 40 ℃ to adjust the pH =3.5 to 4.0. This was filtered off with suction to give 40g of an off-white solid (yield 69.8%).
3) Recovering racemization of dextrorotatory substance: and recovering the dextrorotatory substance B8, weighing 16.3g, putting into a 500ml pressure reaction kettle, and adding 8.8g of potassium hydroxide and 200ml of water. Uniformly mixing, stirring and heating to 180-190 ℃, keeping the temperature for reaction for 5 hours, cooling to 80 ℃ after the reaction is finished, adding activated carbon into the reaction solution for decolorization, adjusting the pH of the filtrate to be =3.5 by hydrochloric acid, and filtering to obtain 12.2g of racemic indoline-2-formic acid with yield of 75%, and optically rotating [ alpha ], [ alpha ]] 25 D =0°。
Comparative example 2
100g of N-acetyl indoline-2-formic acid and 500g of ethanol are put into a 1000ml three-neck flask, and 62g of R (+) -alpha-phenylethylamine is added under stirring. After the addition, the temperature is raised to reflux, and the temperature is kept for 1 hour. Stirring and cooling to 10 deg.C, suction filtering to obtain 120g (purity 3% ee, optically active [ alpha ]] 25 D =-0.5°)。

Claims (13)

1. A resolution method of indoline-2-formic acid compounds is characterized by comprising the following steps: in a solvent, carrying out a salt forming reaction on the compound V and a resolving agent compound II to obtain compounds III and III';
Figure FDA0003954918810000011
the compound V is a mixture of a compound shown in a formula I and a compound shown in a formula I';
Figure FDA0003954918810000012
the compound II is a compound shown as a formula II-1 or a compound shown as a formula II-2;
Figure FDA0003954918810000013
wherein R is 1 is-H, -OH, -NO 2 Or C 1 ~C 3 Alkoxy group of (a);
R 2 is absent or C 1 ~C 3 An alkylene group of (a);
R 3 is C 1 ~C 4 Alkyl groups of (a);
R 4 is C 1 ~C 3 Alkyl, phenyl or tert-butoxy of (a);
when the compound II is a compound II-1, the compounds III and III 'are respectively a compound III-1 and a compound III' -1 shown as follows:
Figure FDA0003954918810000021
when the compound II is a compound II-2, the compounds III and III 'are respectively a compound III-2 and a compound III' -2 shown as follows:
Figure FDA0003954918810000022
2. the method for resolving indoline-2-carboxylic acid compounds of claim 1 wherein R is 1 is-H, -NO 2 Or a methoxy group;
and/or, said R 2 Is absent or C 1 ~C 2 An alkylene group of (a);
and/or, said R 3 Is methyl, ethyl, isopropyl or butyl;
and/or the compound V is a mixture of the compound I and the compound I', and the molar ratio is (2:3) - (3:2);
and/or the compound II is one of enantiomers of phenylglycine methyl ester, phenylglycine ethyl ester, 4-nitrophenylglycine butyl ester, phenylalanine methyl ester, phenylalanine ethyl ester, phenyl butyric acid isopropyl ester or 4-methoxy phenylalanine methyl ester;
and/or the solvent is water and/or an alcohol solvent;
and/or the molar ratio of the compound V to the compound II is (0.95;
and/or the temperature of the salt forming reaction is 50-100 ℃;
and/or the mass ratio of the indoline-2-carboxylic acid compound to the solvent is (1:3) - (1.
3. The method for resolving indoline-2-carboxylic acid compounds according to claim 2 wherein the alcoholic solvent is one or more of methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol and benzyl alcohol;
and/or the compound V is a mixture of the compound I and the compound I ', and the molar ratio of the compound V to the compound I' is 1:1;
and/or the molar ratio of the compound V to the compound II is (1:1) - (1.05;
and/or the mass ratio of the indoline-2-formic acid compound to the solvent is 1:5.
4. The method for resolving indoline-2-carboxylic acid compounds of claim 1 further comprising the steps of: the compound III or III 'and acid are subjected to free reaction to obtain a compound I or I',
Figure FDA0003954918810000031
wherein, the substituent R 1 、R 2 、R 3 And R 4 Are as defined in claim 1.
5. The method for resolving indoline-2-carboxylic acid compounds of claim 4 wherein R is 1 is-H, -NO 2 Or a methoxy group;
and/or, said R 2 Is absent or C 1 ~C 2 An alkylene group of (a);
and/or, said R 3 Is methyl, ethyl, isopropyl or butyl;
and/or the acid is one or more of sulfuric acid, nitric acid, phosphoric acid and hydrochloric acid;
and/or the molar ratio of the compound III or III' to the hydrogen radical ions in the acid is (1:1) - (1.2;
and/or the free reaction temperature is 10-30 ℃.
6. The method for resolving indoline-2-carboxylic acid compounds of claim 5 wherein the acid is hydrochloric acid;
and/or the molar ratio of the compound III or III' to the hydrogen radical ion in the acid is (1.
7. The method for resolving indoline-2-carboxylic acid compounds of claim 4 further comprising the steps of: hydrolyzing the compound I or I 'with acid to obtain a compound IV or IV',
Figure FDA0003954918810000041
wherein, the substituent R 4 Is determined byAs defined in claim 1.
8. The method for resolving indoline-2-carboxylic acid compounds of claim 7 wherein the acid is one or more of sulfuric acid, phosphoric acid and hydrochloric acid;
and/or the molar ratio of the hydrogen radical ions in the acid to the compound I or I' is (2.5;
and/or, the concentration of the acid is 10-15%;
and/or the hydrolysis reaction temperature is 100-110 ℃.
9. The method for resolving indoline-2-carboxylic acid compounds of claim 8 wherein the acid is hydrochloric acid;
and/or the molar ratio of hydrogen radical ions in the acid to the compound I or I' is 3:1;
and/or, the acid concentration is 10%;
and/or the hydrolysis reaction temperature is 100-105 ℃.
10. The method for resolving indoline-2-carboxylic acid compounds of claim 7 further comprising the steps of: and performing racemization reaction on the compound IV or IV 'and acid anhydride to obtain a mixture of the compound IV and the compound IV'.
11. The method for resolving indoline-2-carboxylic acid compounds of claim 10 wherein the anhydride is one or more of acetic anhydride, propionic anhydride, butyric anhydride and phthalic anhydride;
and/or adding an organic solvent in the racemization reaction, wherein the organic solvent is one or more of acetic acid, propionic acid, butyric acid and toluene;
and/or the temperature of the racemization reaction is 100-180 ℃;
and/or, the compound IV and the compound IV' are mixed, and the compound V is further prepared through acylation reaction and the resolution is further carried out.
12. The method for resolving indoline-2-carboxylic acid compounds of claim 11 wherein the temperature of the racemization reaction is 100-120 ℃.
13. A compound of any one of the following:
Figure FDA0003954918810000051
wherein, the substituent R 1 、R 2 、R 3 And R 4 Are as defined in claim 1.
CN201710576038.7A 2017-07-14 2017-07-14 Resolution method of indoline-2-formic acid compound and intermediate thereof Active CN109251163B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710576038.7A CN109251163B (en) 2017-07-14 2017-07-14 Resolution method of indoline-2-formic acid compound and intermediate thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710576038.7A CN109251163B (en) 2017-07-14 2017-07-14 Resolution method of indoline-2-formic acid compound and intermediate thereof

Publications (2)

Publication Number Publication Date
CN109251163A CN109251163A (en) 2019-01-22
CN109251163B true CN109251163B (en) 2022-12-27

Family

ID=65051853

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710576038.7A Active CN109251163B (en) 2017-07-14 2017-07-14 Resolution method of indoline-2-formic acid compound and intermediate thereof

Country Status (1)

Country Link
CN (1) CN109251163B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004182670A (en) * 2002-12-05 2004-07-02 Toray Ind Inc Method for producing optically active 1-protected indoline-2-carboxylic acid derivative and method for producing optically active indoline-2-carboxylic acid derivative
WO2006053440A1 (en) * 2004-11-22 2006-05-26 Apotex Pharmachem Inc. New processes for the preparation of optically pure indoline-2-carboxylic acid and n-acetyl-indoline-2-carboxylic acid
CN101090886A (en) * 2004-12-28 2007-12-19 帝斯曼知识产权资产管理有限公司 Process for the preparation of enantiomerically enriched indoline-2-carboxylic acid
CN101696185A (en) * 2009-11-02 2010-04-21 浙江大学 Synthesizing method of 6-nitro-S-(-)-indoline-2-carboxylic acid
CN102060745A (en) * 2010-11-23 2011-05-18 安徽世华化工有限公司 Preparation method of (S)-indoline-2-carboxylic acid

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004182670A (en) * 2002-12-05 2004-07-02 Toray Ind Inc Method for producing optically active 1-protected indoline-2-carboxylic acid derivative and method for producing optically active indoline-2-carboxylic acid derivative
WO2006053440A1 (en) * 2004-11-22 2006-05-26 Apotex Pharmachem Inc. New processes for the preparation of optically pure indoline-2-carboxylic acid and n-acetyl-indoline-2-carboxylic acid
CN101090886A (en) * 2004-12-28 2007-12-19 帝斯曼知识产权资产管理有限公司 Process for the preparation of enantiomerically enriched indoline-2-carboxylic acid
CN101696185A (en) * 2009-11-02 2010-04-21 浙江大学 Synthesizing method of 6-nitro-S-(-)-indoline-2-carboxylic acid
CN102060745A (en) * 2010-11-23 2011-05-18 安徽世华化工有限公司 Preparation method of (S)-indoline-2-carboxylic acid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
吲哚-2-甲酸和(S)-吲哚啉-2-甲酸的合成和相互转化研究进展;刘金强,等;《有机化学》;20111231;634-645 *

Also Published As

Publication number Publication date
CN109251163A (en) 2019-01-22

Similar Documents

Publication Publication Date Title
EP0057092B1 (en) Process for racemizing an optically active alpha-amino acid or a salt thereof
CN102241555B (en) Method for preparing photoactived amino acid through resolution
CN115073312B (en) Synthesis method of norepinephrine bitartrate
CN114014787A (en) Asymmetric synthesis method for preparing (2S,3R) -p-methylsulfonylphenylserine ethyl ester
HU212703B (en) Process for producing optically active amino acid amide
EP2268827B1 (en) Process of making optically pure melphalan
CN109251163B (en) Resolution method of indoline-2-formic acid compound and intermediate thereof
JP3273578B2 (en) Method for producing salt of ornithine with acidic amino acids or keto acids
US6310242B1 (en) Process for preparing D-alloisoleucine and intermediates for preparation
US5468901A (en) Process for the preparation of optically active methionine amide
CN1226275C (en) Method for preparing dextrorotary phenylalanine by asymmetric conversion method
CN102628075B (en) Method for producing chiral amino acid by penicillin acylase resolution and product thereof
JP3704719B2 (en) Process for producing optically active 3-aminobutanoic acid and its ester intermediate
CN103102280B (en) The preparation method of optical voidness 1-(alpha-amido benzyl)-beta naphthal
JP4532801B2 (en) Method for preparing (-)-(1S, 4R) N protected 4-amino-2-cyclopentene-1-carboxylic acid ester
US4879411A (en) Method for racemization of optically active serine
US4621151A (en) Optical resolution of DL-cysteine
US20110245536A1 (en) Process for preparing pregabalin
CA2575912C (en) Process for the preparation of optically pure indoline-2-carboxylic acid
JP3847934B2 (en) γ-oxo-homophenylalanine derivative and method for producing homophenylalanine derivative obtained by reducing the same
US6008403A (en) Method for producing optically active amino acid of derivative thereof having high optical purity
US6093846A (en) Process for preparing optically active 2-hydroxy-methyl-3-phenylpropionic acid
CN110467539B (en) Resolution method of 2,6-dimethyl tyrosine ester and application thereof
JP4035856B2 (en) Method for producing high optical purity optically active amino acid ester
JP3888402B2 (en) Process for producing optically active N-carbobenzoxy-tert-leucine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20231031

Address after: No. 109 Dengta Road, Changxing Island Economic Zone, Dalian City, Liaoning Province, 116318

Patentee after: Dalian Yongda Suli Pharmaceutical Co.,Ltd.

Address before: 213033 No.5 gangang North Road, Chunjiang Town, Xinbei District, Changzhou City, Jiangsu Province

Patentee before: JIANGSU YONGDA PHARMACEUTICAL Co.,Ltd.